References
Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1(Suppl 1)1):61–85.
Eisenkop SM, Spirtos NM, Friedman RL, Lin WCM, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol. 2003;90(2):390–6.
Berretta R, Capozzi VA, Sozzi G, et al. Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer. Arch Gynecol Obstet. 2018;297(4):997–1004.
Tanaka K, Shimada Y, Nishino K, et al. Clinical significance of mesenteric lymph node involvement in the pattern of liver metastasis in patients with ovarian cancer. Ann Surg Oncol. 2021;28(12):7606–13.
Channawi A, Florin-Catalin P, Charif K, et al. Prognostic impact of mesenteric lymph node status in digestive resection specimens during cytoreductive surgery for ovarian peritoneal metastases. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14405-3.
Funding
None
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors report no conflicts of interest nor funding.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Channawi, A., Pop, FC., Khaled, C. et al. ASO Author Reflections: Mesenteric Lymph Node Involvement in Ovarian Cancer Peritoneal Metastases. Ann Surg Oncol 31, 1806–1807 (2024). https://doi.org/10.1245/s10434-023-14466-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14466-4